Flagship Harbor Advisors, LLC Novavax Inc Transaction History

Flagship Harbor Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 13, 2022	BUY	$69.73 - $142.9 $69,939 - $143,328	1,003 Added 27.87%	4,602 $339,000
Q4 2021 Feb 10, 2022	BUY	$134.56 - $217.97 $484,281 - $784,474	3,599 New	3,599 $515,000
Q4 2020 Feb 08, 2021	SELL	$78.74 - $139.5 $22,834 - $40,455	-290 Closed	0 $0
Q3 2020 Oct 13, 2020	SELL	$79.44 - $178.51 $7,944 - $17,851	-100 Reduced 25.64%	290 $31,000
Q2 2020 Jul 31, 2020	BUY	$13.86 - $83.61 $1,455 - $8,779	105 Added 36.84%	390 $32,000
Q1 2020 May 12, 2020	BUY	$3.93 - $16.0 $923 - $3,760	235 Added 470.0%	285 $4,000
Q2 2019 Jul 22, 2019	BUY	$4.93 - $12.2 $246 - $610	50 New	50 $0

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.